CY1115214T1 - USE OF RANOLAZINE FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OF NUMBERS - Google Patents

USE OF RANOLAZINE FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OF NUMBERS

Info

Publication number
CY1115214T1
CY1115214T1 CY20101100772T CY101100772T CY1115214T1 CY 1115214 T1 CY1115214 T1 CY 1115214T1 CY 20101100772 T CY20101100772 T CY 20101100772T CY 101100772 T CY101100772 T CY 101100772T CY 1115214 T1 CY1115214 T1 CY 1115214T1
Authority
CY
Cyprus
Prior art keywords
treatment
ranolazine
medicine
numbers
preparation
Prior art date
Application number
CY20101100772T
Other languages
Greek (el)
Inventor
Luiz Belardinelli
Charles Antzelevitch
Brent Blackburn
Original Assignee
Gilead Palo Alto, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08004276A external-priority patent/EP1930007B1/en
Application filed by Gilead Palo Alto, Inc. filed Critical Gilead Palo Alto, Inc.
Publication of CY1115214T1 publication Critical patent/CY1115214T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Παρέχονται μέθοδοι για τη θεραπευτική αντιμετώπιση των αρρυθμιών συμπεριλαμβανομένων των ταχυκαρδιών, όπως η ιδιοπαθής κοιλιακή ταχυκαρδία, ή κοιλιακή μαρμαρυγή, και η Torsade de Pontes (TdP) με ένα τρόπο που ελαχιστοποιεί τις ανεπιθύμητες παρενέργειες.Methods are provided for the treatment of arrhythmias including tachycardia, such as idiopathic ventricular tachycardia, or ventricular fibrillation, and Torsade de Pontes (TdP) in a manner that minimizes unwanted side effects.

CY20101100772T 2002-04-04 2010-08-20 USE OF RANOLAZINE FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OF NUMBERS CY1115214T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37015002A 2002-04-04 2002-04-04
US40829202A 2002-09-05 2002-09-05
US42258902A 2002-10-30 2002-10-30
EP08004276A EP1930007B1 (en) 2002-04-04 2003-04-04 Use of ranolazine for the preparation of a medicament for the treatment of early afterdepolarisations (EADs)

Publications (1)

Publication Number Publication Date
CY1115214T1 true CY1115214T1 (en) 2017-01-04

Family

ID=58461537

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100772T CY1115214T1 (en) 2002-04-04 2010-08-20 USE OF RANOLAZINE FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OF NUMBERS

Country Status (1)

Country Link
CY (1) CY1115214T1 (en)

Similar Documents

Publication Publication Date Title
DK1490066T3 (en) Use of ranolazine for the manufacture of a drug for the treatment of arrhythmias
NL300808I2 (en) susoctocog alfa
CY1108845T1 (en) COMBINATIONS CONTAINING AN ANTI-DIAGNOSTIC PRODUCT AND A COPPER OR A COPPER PRODUCER
CY1117217T1 (en) COMPOSITION AND ANTI-VISUAL ACTIVITY OF SUBSTITUTED AZAIDOLOOXOXIC PRODUCERS OF Piperazine
WO2004062479A3 (en) Non-invasive heart treatment device
DE60332355D1 (en) HLA-A24-RESTRICTED CANCERANTEPEPTIDE
CY1110177T1 (en) Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS
CY2014028I1 (en) COMPOUNDS, PHARMACEUTICAL FORMS AND METHODS FOR THE TREATMENT OR PREVENTION OF ACNE ROSEPHUM
IL172396A0 (en) Replikin peptides and uses thereof
EP1803486A3 (en) Method for discriminating between ventricular and supraventricular arrhythmias
MX9204625A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A MAMMAL SPECIES, WHICH SUFFERS FROM CONGESTIVE HEART DEFICIENCY.
DE602005026866D1 (en) USE OF THREE-DIMENSIONAL CULTURED TISSUE FOR THE TREATMENT OF CONGESTIVE HEART FAILURE
CY1110609T1 (en) METHOD FOR PREPARING A SAFEGUARD AGAINST FORMAL ADMINISTRATION
CY1106178T1 (en) 2'- SUBSTITUTED 1,1'-BIPHENYL-2-CARBOXAMIDES, METHOD FOR THEIR PREPARATION, THEIR USE AS A MEDICINE AS WELL AS PHARMACEUTICAL PREPARATIONS COMPRISING THEM
DE60137838D1 (en) DEVICE FOR PERFORMING STERILE MEDICAL TREATMENTS
CY1105941T1 (en) RARγ-SELECTIVE RETINOID AGENTS FOR THE TREATMENT OF EMPHYSEMA
CY1109013T1 (en) NEW 4,4΄-DYPHYTHODES- (3-AMINOBUTANIUM-1-SULPHONIC) PRODUCTS AND COMPOSITIONS CONTAINING THEM
ATE468849T1 (en) IDEBENONE FOR THE TREATMENT OF MUSCLE DYSTROPHIES
ATE233483T1 (en) AQUEOUS SOLUTION FOR PRESERVING TISSUES AND ORGANS
AR032422A1 (en) USE OF IL-18 INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF CARDIAC DISEASE
CY1115214T1 (en) USE OF RANOLAZINE FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OF NUMBERS
DE602008003411D1 (en) USE OF D-RIBOSE FOR THE TREATMENT OF PREVIOUS LIABILITIES
ATE328000T1 (en) PHOSPHOLIPIDE ESTERS OF CLOFARABINE
DE60326931D1 (en) DIFFERENTIALLY EXPRESSED GENEVA PRODUCTS AND THEIR USE PROCEDURES IN CANNULAR MAMMA CELLS
CY1106363T1 (en) USE OF ACTIVATED COAGULATION FACTOR VII IN THE MANAGEMENT OF MAJOR BLEEDING INDUCED BY THROMBOLITIC THERAPY